SCHEMBL7239763

SCHEMBL7239763

O=C(NC(O)CCc1ccccc1)c1cccnc1N1CCN(c2ncccn2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.56
TSHR P16473 2/20 0.56
CAPN1 P07384 3/20 0.54
CTSS P25774 2/20 0.54
CHIA Q9BZP6 1/20 0.47
ATM Q13315 1/20 0.46
KDM4E B2RXH2 2/20 0.45
MAPK1 P28482 1/20 0.44
ALDH1A1 P00352 3/20 0.44
MDM2 Q00987 1/20 0.44
SLC6A7 Q99884 3/20 0.43
MEN1 O00255 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
KMT2A Q03164 1/20 0.42
HTR1A P08908 1/20 0.41
LMNA P02545 2/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7243628 0.92 CAPN1 (0.64) HSD17B10TSHRCAPN1CTSSCHIA
SCHEMBL7241206 0.91 CHIA (0.59) HSD17B10TSHRCAPN1CTSSCHIA
SCHEMBL7242743 0.90 TSHR (0.54) HSD17B10TSHRCAPN1CTSSCHIA
SCHEMBL7241988 0.89 CAPN1 (0.59) HSD17B10TSHRCAPN1CTSSCHIA
SCHEMBL7243112 0.88 TSHR (0.55) HSD17B10TSHRCAPN1CTSSCHIA
SCHEMBL7233171 0.87 CAPN1 (0.57) HSD17B10TSHRCAPN1CTSSCHIA
SCHEMBL7235671 0.87 TSHR (0.52) HSD17B10TSHRCAPN1CTSSCHIA
SCHEMBL7234715 0.85 TSHR (0.49) HSD17B10TSHRCAPN1CTSSCHIA
SCHEMBL7232927 0.85 CAPN1 (0.54) HSD17B10TSHRCAPN1CTSSCHIA
SCHEMBL7243638 0.83 TSHR (0.57) HSD17B10TSHRCAPN1CTSSATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562827-B1 For the treatment of diseases in which increased calpain activity occurs such as neurodegenerative diseases or neuronal damage are caused by ischemia, trauma or mass hemorrhages ABBOTT LABORATORIES 2003-05-13 US disclosed